Pacific Biosciences - Top 15 Biotech VC Deals of 2010

Company: Pacific Biosciences
Based: Menlo Park, CA
Amount: $109M

Investors: Gen-Probe, unnamed investors

Scoop: A perennial contender in our list of the top VC deals each year, Pacific Biosciences once again comes out on top with a $109 million Series F haul. The company is preparing to commercialize its SMRT technology, which uses nanofabrication, biochemistry, molecular biology, surface chemistry and optics to enable real-time analysis of biomolecules. The funding included a $50 million strategic investment made by by Gen-Probe.

This will be the last year PacBio graces this list. The 2009 Fierce 15 company raised $200 million in its initial public offering in October 2010. The company sold 12.5 million shares for $16 each, pricing it in the middle of its targeted $15 to $17 range. All told, PacBio raised $370 million in venture funds before going public.

Pacific Biosciences - Top 15 Biotech VC Deals of 2010
Read more on

Suggested Articles

Pillar is bankrolling a new accelerator for budding biotechs. Petri aims to serve biotech startups at the “frontier of biology and engineering.”

One of the last major, late-stage attempt at stopping Alzheimer’s using a BACE inhibitor has ended up on the trash pile with so many others.

The oligosaccharide microbiome modulator was no better than placebo at reducing lactose intolerance symptoms.